Clairfield advises holding company of Medsen on its majority sale to Bencis
Private equity company Bencis acquired a majority stake in AIO II B.V. from Bolster Investment Partners, which acted on behalf of Van Lanschot Kempen. AIO II is the holding company of Medsen Pharmacies and Ceban.
Medsen Pharmacies is one of the largest independent pharmacy chains in the Netherlands and Ceban is the central Dutch compounding pharmacy. Also included in the transaction was provider of dispensing machines Pharma Robots. The group is headquartered in Breda and records a turnover of € 116 million.
Clairfield acted as advisor to the management of AIO II B.V. in the transaction and in negotiating new shareholder and management terms.
Healthcare
Sale
Advisor to the seller
Services :
Sectors :
Countries involved :
Deal team :
Similar transactions
Zambon, an Italian pharmaceutical multinational, acquired the biotech Breath Therapeutics at an initial price of 140 million euros and with the possibility of reaching a total of 500 million euros at the achievement of regulatory and commercial objectives.
Healthcare
Acquisition
Advisor to the buyer
A stake in Veterinærmedisinsk Oppdragssenter AS (VESO), was sold by the Norwegian Ministry of Trade, Industry and Fisheries (NFD) to Aquanova Invest. VESO distributes veterinary pharmaceuticals as well as performing clinical tests on fish for vaccine and feed development.
Healthcare
Sale
Advisor to the seller
Celopharma, a distributor of female pharmaceutical products, was sold to Linepharma International Ltd., a US subsidiary of a Swiss-based pharmaceutical company.
Healthcare
Sale
Advisor to the seller
Terry White Group (TWG), a pharmacy franchisor with a network of nearly 500 pharmacies across Australia, sold its remaining shares to EBOS Group, the largest and most diversified Australasian marketer, wholesaler, and distributor of healthcare, medical, and pharmaceutical products.
Healthcare
Sale
Advisor to the seller
BJP Laboratories, a leading Australian contract manufacturer of listed medicines, sold 80% of its shares to DZG Investments, the Australian subsidiary of the Goubuli Group, a Chinese food and beverage company.
Healthcare
Sale
Advisor to the seller
